James Gruber Biography and Net Worth

Vice President, US Controller at Horizon Therapeutics, a branded pharmaceutical company where he was responsible for several areas of accounting, finance, and shared services, along with Sarbanes-Oxley compliance and the integration of several acquisitions of both public and private companies

Various finance and accounting roles across multiple divisions of Abbott Laboratories over 14 years within both domestic and international business units of Core Diagnostics, Pharmaceuticals (AbbVie), and Hospital Products (Hospira/Pfizer)

BA, Northwestern University, Kellogg School of Management

BS, Accounting, Indiana University

What is James R. Gruber's net worth?

The estimated net worth of James R. Gruber is at least $6.26 million as of August 19th, 2025. Mr. Gruber owns 205,299 shares of Eton Pharmaceuticals stock worth more than $6,260,593 as of May 7th. This net worth approximation does not reflect any other assets that Mr. Gruber may own. Learn More about James R. Gruber's net worth.

How do I contact James R. Gruber?

The corporate mailing address for Mr. Gruber and other Eton Pharmaceuticals executives is 21925 W. FIELD PARKWAY SUITE 235, DEER PARK IL, 60010. Eton Pharmaceuticals can also be reached via phone at (847) 787-7361 and via email at [email protected]. Learn More on James R. Gruber's contact information.

Has James R. Gruber been buying or selling shares of Eton Pharmaceuticals?

James R. Gruber has not been actively trading shares of Eton Pharmaceuticals during the past quarter. Most recently, James R. Gruber sold 2,631 shares of the business's stock in a transaction on Wednesday, August 20th. The shares were sold at an average price of $16.02, for a transaction totalling $42,148.62. Following the completion of the sale, the chief financial officer now directly owns 204,753 shares of the company's stock, valued at $3,280,143.06. Learn More on James R. Gruber's trading history.

Who are Eton Pharmaceuticals' active insiders?

Eton Pharmaceuticals' insider roster includes Sean Brynjelsen (CEO), James Gruber (CFO), and David Krempa (Chief Business Officer). Learn More on Eton Pharmaceuticals' active insiders.

Are insiders buying or selling shares of Eton Pharmaceuticals?

In the last year, insiders at the sold shares 5 times. They sold a total of 75,713 shares worth more than $1,178,031.37. The most recent insider tranaction occured on August, 20th when CFO James R Gruber sold 2,631 shares worth more than $42,148.62. Insiders at Eton Pharmaceuticals own 16.5% of the company. Learn More about insider trades at Eton Pharmaceuticals.

Information on this page was last updated on 8/20/2025.